Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)

Market Cap	22.35B +15.3%
Revenue (ttm)	2.16B +14.2%
Net Income	437.00M +144.8%
EPS	0.74 +144.1%
Shares Out	587.29M
PE Ratio	51.50
Forward PE	44.29
Dividend	0.43 (1.14%)
Ex-Dividend Date	Dec 3, 2025

Volume	122,943
Average Volume	450,422
Open	37.90
Previous Close	38.05
Day's Range	37.90 - 38.66
52-Week Range	32.50 - 41.40
Beta	0.91
RSI	49.91
Earnings Date	May 28, 2026

About NZE:FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,440
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: FPH

Financial Performance

In fiscal year 2025, NZE:FPH's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.